EAU 2013 - Programme Book - YouMed

Monday, 18 March - EAU Programme
Abstract Session
14.00 - 15.30 Prostate cancer cell biology and signaling
Amber Hall 1-2 - Level S2
Poster Session 77
Chairs: G. Jenster, Rotterdam (NL)
H.Y. Leung, Glasgow (GB)
Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes
in length, followed by 2 minutes for discussion.
935 Activation of HIF1α promotes androgen independent prostate cancer cell growth
M. Tran, F. Lo, A. Ramos-Montoya, H. Scott, S. Menon, T. Carroll, M. Osborne, J. Hadfield, S. Cheung,
A. Warren, D. Shukla, C. Massie, P. Maxwell, I. Mills, D. Neal (Cambridge, United Kingdom)
936 MiR-221 targets IRF2 and SOCS3 - two negative regulators of the JAK/STAT pathway - and inhibits their
expression in prostate cancer
M. Spahn, M. Krebs, M. Schubert, H. Riedmiller, B. Kneitz (Berne, Switzerland; Würzburg, Germany)
937 Wnt signaling protein (Wisp2/CCN5) stimulates angiogenesis and invasion in prostate cancer
Y. Hashimoto, R. Singh, B. Lokeshwar (Tokyo, Japan; Miami, United States of America)
938 Metformin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the
insulin-like growth factor 1 receptor
H. Kato, Y. Sekine, Y. Miyazawa, Y. Furuya, H. Koike, K. Suzuki (Maebashi, Japan)
939 ERp46 mediates prostate cancer tumorigenesis in vitro by inhibiting adiponectin-induced tumorsuppressive
effects - linking obesity to prostate cancer
J. Pinthus, S. Hopmans, A. Paschos, R. Austin, W. Duivenvoorden (Hamilton, Canada)
940 Sonic hedgehog signaling and androgens are linked in tumor-stromal interaction through Epithelial-
Mesenchymal Transition (EMT) in prostate cancer progression
K. Shigemura, F. Yamamichi, T. Shirakawa, H. Miyake, K. Tanaka, M. Fujisawa (Kobe, Japan)
941 Loss of Dickkopf-3 expression impairs prostate acinar morphogenesis via aberrant TGF-β/Smad signalling
activation
Y. Kawano, D. Romero, N. Bengoa, N. Maltry, M. Walker, M. Eto, J. Waxman, C. Niehrs, R. Kypta (Kumamoto,
Japan; London, United Kingdom; Bilbao, Spain; Heidelberg, Germany)
942 Cancer cell specific transcriptome analysis of stroma-cancer interactions in mouse xenograft models of
bone metastasis
G.N. Thalmann, J. Hensel, B. Özdemir, A. Wetterwald, M. Delorenzi, M.G. Cecchini (Berne, Lausanne,
Switzerland)
943 Epigenetic and transcriptional mechanisms by which MYC regulates rRNA levels
M. Uemura, S. Yegnasubramanian, W.G Nelson, N. Nonomura, A.M De Marzo (Suita, Japan; Baltimore,
United States of America)
944 Computerized quantification and planimetry of prostatic capsular nerves in relation to adjacent cancer foci
J. Bründl, S. Schneider, F. Zeman, W.F. Wieland, R. Ganzer (Regensburg, Germany)
945 The genomic evolution of prostate cancer under the selective pressure of anti-androgen therapy
J.R. Gsponer, T. Dietsche, A. Rufle, E. Lenkiewicz, T. Zellweger, A. Bachmann, M.T. Barrett, C.A. Rentsch,
C. Ruiz, L. Bubendorf (Basel, Switzerland; Scottsdale, United States of America)
EAU Milan 2013
287
Monday